Order Article Reprints

Mohammed OA, Abdel-Reheim MA, Alamri MMS, Alfaifi J, Adam MIE, Saleh LA, Farrag AA, Yahia AIO, Abdel-Ghany S, AlQahtani AAJ, et al. STA9090 as a Potential Therapeutic Agent for Liver Fibrosis by Modulating the HSP90/TβRII/Proteasome Interplay: Novel Insights from In Vitro and In Vivo Investigations. Pharmaceuticals. 2023; 16(8):1080. https://doi.org/10.3390/ph16081080

Mohammed, Osama A., Mustafa Ahmed Abdel-Reheim, Mohannad Mohammad S. Alamri, Jaber Alfaifi, Masoud I. E. Adam, Lobna A. Saleh, Alshaimaa A. Farrag, Amar Ibrahim Omer Yahia, Sameh Abdel-Ghany, AbdulElah Al Jarallah AlQahtani, and et al. 2023. "STA9090 as a Potential Therapeutic Agent for Liver Fibrosis by Modulating the HSP90/TβRII/Proteasome Interplay: Novel Insights from In Vitro and In Vivo Investigations" Pharmaceuticals 16, no. 8: 1080. https://doi.org/10.3390/ph16081080

Mohammed, O. A., Abdel-Reheim, M. A., Alamri, M. M. S., Alfaifi, J., Adam, M. I. E., Saleh, L. A., Farrag, A. A., Yahia, A. I. O., Abdel-Ghany, S., AlQahtani, A. A. J., Bahashwan, E., Eltahir, H. B., Mohammed, N. A., El-wakeel, H. S., Hazem, S. H., & Saber, S. (2023). STA9090 as a Potential Therapeutic Agent for Liver Fibrosis by Modulating the HSP90/TβRII/Proteasome Interplay: Novel Insights from In Vitro and In Vivo Investigations. Pharmaceuticals, 16(8), 1080. https://doi.org/10.3390/ph16081080